Analysis Report
Representative Director Kim Myung-cheol In-depth Analysis
Instar Plastic Surgery is an aesthetic plastic surgery institution located on Gangnam-daero, Gangnam-gu, Seoul (near Gangnam Station Exit 11), which established its current name through a rebranding in March 2018.
Representative Director Kim Myung-cheol is a veteran plastic surgery specialist with approximately 28 years of experience as a doctor. Since obtaining his board certification in 2007, he has served as a director at major domestic hospitals.
The clinic promotes 'Non-double eyelid ptosis correction' and 'UU Breast Surgery' as specialized treatment subjects, emphasizing a surgical philosophy that pursues both naturalness and functional improvement simultaneously.
While maintaining high ratings of 9.2~9.3 on aesthetic medical platforms, plastic surgery communities show a coexistence of positive evaluations and critical reviews regarding post-operative care.
"This report offers a multi-faceted analysis of Instar Plastic Surgery and its leader, Representative Director Kim Myung-cheol, comprehensively reviewing its history, the director's philosophy, technical characteristics, and reputation."
Representative Director Kim Myung-cheol is the key figure of Instar Plastic Surgery, whose career aligns with the growth of the Korean plastic surgery market. With approximately 28 years of medical experience, his extensive clinical experience at large hospitals is considered his main competitive edge.
Medical Institution Name: Instar Plastic Surgery Clinic
Representative: Kim Myung-cheol
Location: 7F, Glass Tower, 406 Gangnam-daero, Gangnam-gu, Seoul (near Gangnam Station Exit 11), a prime location known as the mecca of Korean plastic surgery.
Establishment & Rebranding: Rebranded to 'Instar Plastic Surgery' in March 2018 to differentiate from existing brands and consider pronunciation convenience for foreign patients.
Medical Hours: Weekdays 10:00~19:00, Saturdays 10:00~16:00 (Closed on Sundays and Public Holidays).
While 'Instar' evokes the social media platform 'Instagram', the hospital's official explanation states it is strategic naming meant to build a popular and friendly image along with the meaning "For you who shines like a star." This targets both the beauty-conscious 2030 generation and foreign patients.
Instar Plastic Surgery prioritizes patient safety, implementing robust systems to ensure a secure surgical environment.
While Instar Plastic Surgery performs general plastic surgery treatments, data analysis shows it stands out particularly in Eye Surgery (especially Non-double eyelid ptosis correction) and Breast Surgery.
A surgery that strengthens the power of the eye-opening muscle to increase pupil exposure without creating a double eyelid line or making it visible externally.
Performs various slit surgeries such as Epicanthoplasty (front), Lateral Canthoplasty (back), Lower Canthoplasty (bottom), and 4-way Canthoplasty.
Instar Plastic Surgery's breast surgery brand aimed at creating a water drop shape or natural line (UU line) similar to real breasts, rather than an unnatural 'overturned rice bowl' shape.
Performs surgeries that solve functional problems such as deviated septum simultaneously with aesthetic improvement. Possesses expertise in reconstructive plastic surgery for side effects.
The reputation of Instar Plastic Surgery and Director Kim Myung-cheol shows somewhat different patterns depending on the nature of the platform, offering a comprehensive view.
Gangnam Unni / Babitalk:
Very Excellent
(High popular satisfaction, combined marketing & actual satisfaction)
Sungyesa:
Medium-High to Good (3.5/5.0)
(More cool-headed & critical consumers, higher reliability due to broker blocking)
Instar Plastic Surgery is a hospital backed by **'Veteran Doctor's Know-how'** behind its marketing efforts. It is a choice worth considering primarily for patients seeking natural eye correction. However, before deciding on surgery, it is highly advisable to obtain an accurate diagnosis through face-to-face consultation and thoroughly discuss the possibility of side effects.